Cargando…

Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system

OBJECTIVES: To evaluate the cost-effectiveness of biologics and methotrexate (MTX) for rheumatoid arthritis (RA) using the number needed to treat (NNT) concept and total actual health care cost. METHODS: This study included 121 RA patients with newly prescribed biologics and/or MTX between 2012 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harigane, Kengo, Mochida, Yuichi, Shimazaki, Takayuki, Kobayashi, Naomi, Inaba, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944043/ https://www.ncbi.nlm.nih.gov/pubmed/35331233 http://dx.doi.org/10.1186/s12962-022-00347-2

Ejemplares similares

Risk factors associated with cervical spine lesions in patients with rheumatoid arthritis: an observational study
por: Uchino, Yosuke, et al.
Publicado: (2021)

Good long-term outcome of synovectomy in advanced stages of the rheumatoid elbow: 64 elbows followed for 10–23 years
por: Ishii, Katsushi, et al.
Publicado: (2012)

Pharmacoeconomics for migraine and headache researchers: basic concepts, methods and terminology
por: Walley, Tom
Publicado: (2004)

Pharmacoeconomical Concept in the Book of Rhazes, 10(th) Century AD
por: Hosseinkhani, Ayda, et al.
Publicado: (2019)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Standpoint cosmology
por: Chew, Geoffrey Foucar
Publicado: (1994)

The Medical Standpoint
Publicado: (1921)

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis
por: Okada, Morihiro, et al.
Publicado: (2017)

Pharmacoeconomic evaluation of treatment effectiveness with selected biologic treatment in rheumatoid arthritis therapy
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis
por: Hashiguchi, Masayuki, et al.
Publicado: (2016)

Classical standpoint cosmology
por: Chew, Geoffrey Foucar
Publicado: (1994)

The Standpoint of the Other Fellow
Publicado: (1899)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
por: Hashimoto, Hiroko, et al.
Publicado: (2021)

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)

Drug Policy Research & Pharmacoeconomics
Publicado: (2008)

Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007)

Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
por: Takeuchi, Tsutomu, et al.
Publicado: (2018)

The new 2012 German recommendations for treating rheumatoid arthritis: Differences compared to the European standpoint
por: Wollenhaupt, J., et al.
Publicado: (2013)

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
por: Benucci, Maurizio, et al.
Publicado: (2017)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2015)

Standpoint coherent-state cosmology
por: Chew, Geoffrey Foucar
Publicado: (1994)

Applications of classical standpoint cosmology
por: Chew, Geoffrey Foucar
Publicado: (1995)

Housekeeping from the Higher Standpoint
por: Oakeley, Hilda D.
Publicado: (1911)

Appendicitis from the Standpoint of the Physician
Publicado: (1904)

Antisepsis from the Later Standpoint
Publicado: (1884)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014)

Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

Pharmacoeconomics in Africa: needs, prospect and challenges
por: Ben-Ajepe, Temitope, et al.
Publicado: (2021)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmacoeconomic Challenges in the Management of Diabetic Nephropathy
por: Rodby, Roger A.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hjpu27ncdpscp7ruumt4d67o4h